查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1571548

商業生物技術分離系統市場規模、佔有率、趨勢分析報告：按方法、按應用、按地區、細分市場預測，2024-2030 年

Separation Systems For Commercial Biotechnology Market Size, Share & Trends Analysis Report By Method (Conventional Methods, Modern Methods), By Application (Pharmaceutical, Food & Cosmetics), By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

商業生物技術分離系統市場成長與趨勢：

Grand View Research, Inc. 的最新報告顯示，全球商業生物技術分離系統市場預計到 2030 年將達到 405.5 億美元，2024 年至 2030 年複合年成長率為 6.8%。

生物技術領域的深入研究以開發先進產品預計將推動未來幾年的成長。此外，為了加速商業生產，該領域領先工業營業單位的貢獻預計將推動市場。

政府機構為中小企業開發新技術提供資金。預計這將提高用於分離和精製生物分子的大規模上游生物製程系統的效率。此類設備廣泛應用於食品和化妝品、農業、塑膠和化學產品的生產。

此外，技術先進的一次性生物製程系統在農產品加工、化學品和塑膠等各行業的普及也促進了上游加工產業的成長。患有慢性和嚴重代謝和遺傳疾病的患者數量不斷增加，最終增加了對潛在治療藥物的需求。對生物製藥的需求不斷成長可能會帶來利潤豐厚的成長。

此外，醫療改革的變化以及產業、政府和研究機構之間的公私合作預計將改善分離法的技術方面。因此，預計將在預測期內顯著推動商業分離市場的成長。

商業生物技術分離系統市場報告亮點

  • 由於該領域的技術進步，傳統分離技術預計將佔據最大的收益佔有率。
  • 然而，由於這些技術的採用越來越多，預計現代方法在未來幾年將以最快的速度成長。
  • 產品性能的技術進步預計將推動商業生物技術分離系統市場的發展。
  • 由於治療商業化系統的高利用率，製藥業佔據了最大的收益佔有率。
  • 各種慢性病盛行率的上升間接支持了經濟成長。
  • 北美由於充足的行政支持、廣泛的研究和成熟的產業框架而在市場上佔據主導地位。
  • 由於先進的工業化和政府的有利支持，預計亞太地區將在預測期內呈現最快的成長。
  • 私人公司與學術機構、私人公司和公共組織合作，加速產品開發並推出新系統。

目錄

第1章調查方法和範圍

第 2 章執行摘要

第 3 章 商業生物技術分離系統的變數、趨勢與範圍

  • 市場介紹/系統展望
  • 市場規模及成長前景
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 商業生物技術分離系統市場分析工具
    • 波特的分析
    • PESTEL分析

第 4 章商業生物技術的分離系統：方法評估與趨勢分析

  • 細分儀表板
  • 商業生物技術的分離系統：方法變異分析，2023 年和 2030 年
  • 傳統方法
  • 現代方法

第5章商業生物技術的分離系統：應用評估與趨勢分析

  • 細分儀表板
  • 商業生物技術分離系統：應用變化分析，2023 年和 2030 年
  • 製藥
    • 疫苗
    • 蛋白質
    • 荷爾蒙/胰島素
    • 酵素
    • 人血漿分餾
    • 哺乳動物細胞培養
  • 食品/化妝品
  • 農業
  • 其他

第 6 章 商業生物技術的分離系統：區域估計與趨勢分析

  • 2023 年和 2030 年商業生物技術分離系統的市場佔有率（按地區）
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第7章 競爭格局

  • 主要市場參與企業的最新趨勢和影響分析
  • 公司分類
  • 企業熱力圖分析
  • 公司簡介
    • Thermo Fisher Scientific Inc.
    • QIAGEN
    • Horizon Discovery Ltd.
    • OriGene Technologies, Inc.
    • Oxford Biomedica PLC
    • SignaGen Laboratories
    • Flash Therapeutics
    • Takara Bio Inc.
    • Bio-Rad Laboratories, Inc.
    • System Biosciences, LLC.
    • Promega Corporation
    • F. Hoffmann-La Roche Ltd
    • Revvity
    • Catalent, Inc
簡介目錄
Product Code: GVR-2-68038-841-1

Separation Systems For Commercial Biotechnology Market Growth & Trends:

The global separation system for commercial biotechnology market size is expected to reach USD 40.55 billion by 2030, expanding at a CAGR of 6.8% from 2024 to 2030, according to a new report by Grand View Research, Inc. Intensive research in the field of biotechnology to develop advanced products is expected to boost growth in the coming years. Moreover, contributions of leading industrial entities in this sector for accelerating commercial production is anticipated to drive the market.

Government bodies are providing funds to small & medium enterprises for the development of novel technologies. This is expected to enhance the efficiency of large-scale upstream bioprocessing systems used for separation & purification of biomolecules. Such instruments are extensively used for the production of food & cosmetics, agriculture, plastics, and chemicals.

Moreover, the popularity of technologically advanced single-use bioprocessing systems in various industries, such as agro-processing, chemical & plastics is contributing toward the growth of the upstream processing sector. Rising cases of chronic & severe metabolic & genetic disorders are ultimately increasing the demand for potential therapeutics. Rising demand for biopharmaceuticals is likely to result in lucrative growth.

Furthermore, changing healthcare reforms and public-private collaborations among industrial players, government, and research institutions are expected to improve the technological aspects of separation methods. Thus, in turn, is anticipated to significantly render the growth of commercial separation market over the forecast period.

Separation Systems For Commercial Biotechnology Market Report Highlights:

  • Conventional separation techniques are estimated to account for the largest revenue share owing to technological advancements in the segment.
  • However, modern methods are anticipated to grow at the fastest pace in the coming years due to the rise in adoption of these technologies.
  • Technological advancements in product capabilities are anticipated to boost the separation systems for commercial biotechnology market.
  • Pharmaceutical industry accounted for the largest revenue share owing to higher usage of systems for commercialization of therapeutics.
  • Rising prevalence of various chronic disorders is indirectly boosting growth.
  • North America dominated the market with adequate administrative support, extensive research, and well-established industrial framework.
  • Asia Pacific region is expected to exhibit the fastest growth over the forecast period owing to progressive industrialization and favorable government support.
  • Companies are entering into collaborations with academic institutions, private, and public entities to accelerate product development and launch novel systems.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
    • 1.3.1. Information Procurement
    • 1.3.2. Information or Data Analysis
    • 1.3.3. Market Formulation & Data Visualization
    • 1.3.4. Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Separation Systems for Commercial Biotechnology Market Variables, Trends, & Scope

  • 3.1. Market Introduction/Lineage Outlook
  • 3.2. Market Size and Growth Prospects (USD Million)
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers Analysis
    • 3.3.2. Market Restraints Analysis
  • 3.4. Separation Systems for Commercial Biotechnology Market Analysis Tools
    • 3.4.1. Porter's Analysis
      • 3.4.1.1. Bargaining power of the suppliers
      • 3.4.1.2. Bargaining power of the buyers
      • 3.4.1.3. Threats of substitution
      • 3.4.1.4. Threats from new entrants
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Economic and Social landscape
      • 3.4.2.3. Technological landscape
      • 3.4.2.4. Environmental landscape
      • 3.4.2.5. Legal landscape

Chapter 4. Separation Systems for Commercial Biotechnology Market: Method Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Separation Systems for Commercial Biotechnology Market: Method Movement Analysis, 2023 & 2030 (USD Million)
  • 4.3. Conventional Methods
    • 4.3.1. Conventional Methods Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.2. Chromatography
      • 4.3.2.1. Chromatography Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.3. Flow Cytometry
      • 4.3.3.1. Flow Cytometry Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.4. Membrane Filtration
      • 4.3.4.1. Membrane Filtration Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.5. Electrophoresis
      • 4.3.5.1. Electrophoresis Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.6. Centrifugation
      • 4.3.6.1. Centrifugation Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4. Modern Methods
    • 4.4.1. Modern Methods Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.2. Microarray
      • 4.4.2.1. Microarray Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.3. Lab-on-a-chip
      • 4.4.3.1. Lab-on-a-chip Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.4. Magnetic Separation
      • 4.4.4.1. Magnetic Separation Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.5. Biochip
      • 4.4.5.1. Biochip Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Separation Systems for Commercial Biotechnology Market: Application Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Separation Systems for Commercial Biotechnology Market: Application Movement Analysis, 2023 & 2030 (USD Million)
  • 5.3. Pharmaceutical
    • 5.3.1. Pharmaceutical Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.3.2. Vaccines
      • 5.3.2.1. Vaccines Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.3.3. Proteins
      • 5.3.3.1. Proteins Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.3.4. Hormones/Insulin
      • 5.3.4.1. Hormones/Insulin Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.3.5. Enzymes
      • 5.3.5.1. Enzymes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.3.6. Human Blood Plasma Fractionation
      • 5.3.6.1. Human Blood Plasma Fractionation Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.3.7. Mammalian Cell Cultures
      • 5.3.7.1. Mammalian Cell Cultures Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4. Food & Cosmetics
    • 5.4.1. Food & Cosmetics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Agriculture
    • 5.5.1. Agriculture Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6. Others
    • 5.6.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Separation Systems for Commercial Biotechnology Market: Regional Estimates & Trend Analysis

  • 6.1. Separation Systems for Commercial Biotechnology Market Share, By Region, 2023 & 2030 (USD Million)
  • 6.2. North America
    • 6.2.1. North America Separation Systems for Commercial Biotechnology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.2.2. U.S.
      • 6.2.2.1. U.S. Separation Systems for Commercial Biotechnology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.2.3. Canada
      • 6.2.3.1. Canada Separation Systems for Commercial Biotechnology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.2.4. Mexico
      • 6.2.4.1. Mexico Separation Systems for Commercial Biotechnology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.3. Europe
    • 6.3.1. Europe Separation Systems for Commercial Biotechnology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.2. UK
      • 6.3.2.1. UK Separation Systems for Commercial Biotechnology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.3. Germany
      • 6.3.3.1. Germany Separation Systems for Commercial Biotechnology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.4. France
      • 6.3.4.1. France Separation Systems for Commercial Biotechnology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.5. Italy
      • 6.3.5.1. Italy Separation Systems for Commercial Biotechnology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.6. Spain
      • 6.3.6.1. Spain Separation Systems for Commercial Biotechnology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.7. Denmark
      • 6.3.7.1. Denmark Separation Systems for Commercial Biotechnology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.8. Sweden
      • 6.3.8.1. Sweden Separation Systems for Commercial Biotechnology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.9. Norway
      • 6.3.9.1. Norway Separation Systems for Commercial Biotechnology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4. Asia Pacific
    • 6.4.1. Asia Pacific Separation Systems for Commercial Biotechnology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.2. Japan
      • 6.4.2.1. Japan Separation Systems for Commercial Biotechnology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.3. China
      • 6.4.3.1. China Separation Systems for Commercial Biotechnology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.4. India
      • 6.4.4.1. India Separation Systems for Commercial Biotechnology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.5. Australia
      • 6.4.5.1. Australia Separation Systems for Commercial Biotechnology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.6. South Korea
      • 6.4.6.1. South Korea Separation Systems for Commercial Biotechnology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.7. Thailand
      • 6.4.7.1. Thailand Separation Systems for Commercial Biotechnology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Latin America
    • 6.5.1. Latin America Separation Systems for Commercial Biotechnology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.2. Brazil
      • 6.5.2.1. Brazil Separation Systems for Commercial Biotechnology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.3. Argentina
      • 6.5.3.1. Argentina Separation Systems for Commercial Biotechnology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Middle East and Africa
    • 6.6.1. Middle East and Africa Separation Systems for Commercial Biotechnology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.2. South Africa
      • 6.6.2.1. South Africa Separation Systems for Commercial Biotechnology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.3. Saudi Arabia
      • 6.6.3.1. Saudi Arabia Separation Systems for Commercial Biotechnology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.4. UAE
      • 6.6.4.1. UAE Separation Systems for Commercial Biotechnology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.5. Kuwait
      • 6.6.5.1. Kuwait Separation Systems for Commercial Biotechnology Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis by Key Market Participants
  • 7.2. Company Categorization
  • 7.3. Company Heat Map Analysis
  • 7.4. Company Profiles
    • 7.4.1. Thermo Fisher Scientific Inc.
      • 7.4.1.1. Participant's Overview
      • 7.4.1.2. Financial Performance
      • 7.4.1.3. Product Benchmarking
      • 7.4.1.4. Recent Developments/Strategic Initiatives
    • 7.4.2. QIAGEN
      • 7.4.2.1. Participant's Overview
      • 7.4.2.2. Financial Performance
      • 7.4.2.3. Product Benchmarking
      • 7.4.2.4. Recent Developments/Strategic Initiatives
    • 7.4.3. Horizon Discovery Ltd.
      • 7.4.3.1. Participant's Overview
      • 7.4.3.2. Financial Performance
      • 7.4.3.3. Product Benchmarking
      • 7.4.3.4. Recent Developments/Strategic Initiatives
    • 7.4.4. OriGene Technologies, Inc.
      • 7.4.4.1. Participant's Overview
      • 7.4.4.2. Financial Performance
      • 7.4.4.3. Product Benchmarking
      • 7.4.4.4. Recent Developments/Strategic Initiatives
    • 7.4.5. Oxford Biomedica PLC
      • 7.4.5.1. Participant's Overview
      • 7.4.5.2. Financial Performance
      • 7.4.5.3. Product Benchmarking
      • 7.4.5.4. Recent Developments/Strategic Initiatives
    • 7.4.6. SignaGen Laboratories
      • 7.4.6.1. Participant's Overview
      • 7.4.6.2. Financial Performance
      • 7.4.6.3. Product Benchmarking
      • 7.4.6.4. Recent Developments/Strategic Initiatives
    • 7.4.7. Flash Therapeutics
      • 7.4.7.1. Participant's Overview
      • 7.4.7.2. Financial Performance
      • 7.4.7.3. Product Benchmarking
      • 7.4.7.4. Recent Developments/Strategic Initiatives
    • 7.4.8. Takara Bio Inc.
      • 7.4.8.1. Participant's Overview
      • 7.4.8.2. Financial Performance
      • 7.4.8.3. Product Benchmarking
      • 7.4.8.4. Recent Developments/Strategic Initiatives
    • 7.4.9. Bio-Rad Laboratories, Inc.
      • 7.4.9.1. Participant's Overview
      • 7.4.9.2. Financial Performance
      • 7.4.9.3. Product Benchmarking
      • 7.4.9.4. Recent Developments/Strategic Initiatives
    • 7.4.10. System Biosciences, LLC.
      • 7.4.10.1. Participant's Overview
      • 7.4.10.2. Financial Performance
      • 7.4.10.3. Product Benchmarking
      • 7.4.10.4. Recent Developments/Strategic Initiatives
    • 7.4.11. Promega Corporation
      • 7.4.11.1. Participant's Overview
      • 7.4.11.2. Financial Performance
      • 7.4.11.3. Product Benchmarking
      • 7.4.11.4. Recent Developments/Strategic Initiatives
    • 7.4.12. F. Hoffmann-La Roche Ltd
      • 7.4.12.1. Participant's Overview
      • 7.4.12.2. Financial Performance
      • 7.4.12.3. Product Benchmarking
      • 7.4.12.4. Recent Developments/Strategic Initiatives
    • 7.4.13. Revvity
      • 7.4.13.1. Participant's Overview
      • 7.4.13.2. Financial Performance
      • 7.4.13.3. Product Benchmarking
      • 7.4.13.4. Recent Developments/Strategic Initiatives
    • 7.4.14. Catalent, Inc
      • 7.4.14.1. Participant's Overview
      • 7.4.14.2. Financial Performance
      • 7.4.14.3. Product Benchmarking
      • 7.4.14.4. Recent Developments/Strategic Initiatives